GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 112 filers reported holding GENMARK DIAGNOSTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $2,159,939 | – | 524,257 | – | 0.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 950,000 | $9,823,000 | 1.01% |
| Curi RMB Capital, LLC | 939,265 | $9,720,000 | 0.74% |
| KOPP INVESTMENT ADVISORS LLC | 96,384 | $997,000 | 0.39% |
| Alyeska Investment Group, L.P. | 314,502 | $3,254,000 | 0.16% |
| PFM Health Sciences, LP | 604,199 | $6,252,000 | 0.13% |
| Spark Investment Management LLC | 47,000 | $485,000 | 0.13% |
| ELLINGTON MANAGEMENT GROUP LLC | 61,700 | $638,000 | 0.12% |
| PUTNAM INVESTMENTS LLC | 1,745,494 | $18,048,000 | 0.05% |
| PointState Capital LP | 298,976 | $3,094,000 | 0.05% |
| Partner Investment Management, L.P. | 20,717 | $214,000 | 0.05% |